199 related articles for article (PubMed ID: 28185222)
1. Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series.
Murri R; Fiori B; Spanu T; Mastrorosa I; Giovannenze F; Taccari F; Palazzolo C; Scoppettuolo G; Ventura G; Sanguinetti M; Cauda R; Fantoni M
Infection; 2017 Apr; 45(2):209-213. PubMed ID: 28185222
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.
Freire MP; Abdala E; Moura ML; de Paula FJ; Spadão F; Caiaffa-Filho HH; David-Neto E; Nahas WC; Pierrotti LC
Infection; 2015 Jun; 43(3):315-23. PubMed ID: 25690848
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
[TBL] [Abstract][Full Text] [Related]
4. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
[TBL] [Abstract][Full Text] [Related]
8. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.
Bergamasco MD; Barroso Barbosa M; de Oliveira Garcia D; Cipullo R; Moreira JC; Baia C; Barbosa V; Abboud CS
Transpl Infect Dis; 2012 Apr; 14(2):198-205. PubMed ID: 22093103
[TBL] [Abstract][Full Text] [Related]
9. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.
Tofas P; Skiada A; Angelopoulou M; Sipsas N; Pavlopoulou I; Tsaousi S; Pagoni M; Kotsopoulou M; Perlorentzou S; Antoniadou A; Pirounaki M; Skoutelis A; Daikos GL
Int J Antimicrob Agents; 2016 Apr; 47(4):335-9. PubMed ID: 27005460
[TBL] [Abstract][Full Text] [Related]
10. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
11. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.
Lübbert C; Lippmann N; Busch T; Kaisers UX; Ducomble T; Eckmanns T; Rodloff AC
Am J Infect Control; 2014 Apr; 42(4):376-80. PubMed ID: 24679563
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
13. Characterization of KPC-type carbapenemase-producing Klebsiella pneumoniae strains isolated in the Arabian Peninsula.
Sonnevend Á; Ghazawi A; Darwish D; AlDeesi Z; Kadhum AF; Pál T
J Antimicrob Chemother; 2015 May; 70(5):1592-3. PubMed ID: 25608586
[No Abstract] [Full Text] [Related]
14. Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy.
Brescini L; Morroni G; Valeriani C; Castelletti S; Mingoia M; Simoni S; Masucci A; Montalti R; Vivarelli M; Giacometti A; Barchiesi F
BMC Infect Dis; 2019 Jul; 19(1):611. PubMed ID: 31299943
[TBL] [Abstract][Full Text] [Related]
15. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization.
Sbrana F; Malacarne P; Bassetti M; Tascini C; Vegnuti L; Della Siega P; Ripoli A; Ansaldi F; Menichetti F
Minerva Anestesiol; 2016 Jun; 82(6):635-40. PubMed ID: 26745619
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
[TBL] [Abstract][Full Text] [Related]
18. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.
Papadimitriou-Olivgeris M; Fligou F; Bartzavali C; Zotou A; Spyropoulou A; Koutsileou K; Vamvakopoulou S; Sioulas N; Karamouzos V; Anastassiou ED; Spiliopoulou I; Christofidou M; Marangos M
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1125-1131. PubMed ID: 28102514
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
Russo A; Giuliano S; Ceccarelli G; Alessandri F; Giordano A; Brunetti G; Venditti M
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555630
[TBL] [Abstract][Full Text] [Related]
20. Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy.
Giuffrè M; Bonura C; Geraci DM; Saporito L; Catalano R; Di Noto S; Nociforo F; Corsello G; Mammina C
J Hosp Infect; 2013 Nov; 85(3):233-6. PubMed ID: 24074641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]